Results 121 to 130 of about 226,507 (202)

Retinal pigment epithelium cholesterol efflux mediated by the 18kDa translocator protein, TSPO, a potential target for treating age-related macular degeneration [PDF]

, 2017
Biswas, Lincoln, Dhillon, Baljean, Graham, Annette, Shu, Xinhua, Zhou, Xinzhi   +4 more
core   +2 more sources

Sphingosine 1-phosphate receptor 1signaling in macrophages reduces atherosclerosis in LDL receptor-deficient mice. [PDF]

JCI Insight
Potì F, Scalera E, Feuerborn R, Fischer J, Arndt L, Varga G, Pardali E, Seidl MD, Fobker M, Liebisch G, Hesse B, Lukasz AH, Rossaint J, Kehrel BE, Rosenbauer F, Renné T, Christoffersen C, Simoni M, Burkhardt R, Nofer JR.   +19 more
europepmc   +1 more source

Receptor-mediated cellular uptake of cyclosporine [PDF]

, 1989
Diven, WF, Sanghvi, A, Starzl, T, Warty, VS   +3 more
core  

The LDL receptor-related protein 1 (LRP1) facilitates ACE2-mediated endocytosis of SARS-CoV2 spike protein-containing pseudovirions. [PDF]

J Biol Chem
Wani MM, Cooper JM, Migliorini M, Strickland DK.   +3 more
europepmc   +1 more source

Atorvastatin enhances LDL receptor-mediated LDL-C uptake and modulates PCSK9 protein expression in pancreatic β-cells. [PDF]

Islets
Zhang Z, Zheng H, Zhang L, Su P, Chen X, Xiang A, Yang J, Guan H, Fan J, Yu Q.   +9 more
europepmc   +1 more source

Gene expression patterns of the LDL receptor and its inhibitor Pcsk9 in the adult zebrafish brain suggest a possible role in neurogenesis. [PDF]

Eur J Neurosci
Gence L, Morello E, Rastegar S, Apalama ML, Meilhac O, Bascands JL, Diotel N.   +6 more
europepmc   +1 more source

Apolipoprotein O modulates cholesterol metabolism via NRF2/CYB5R3 independent of LDL receptor. [PDF]

Cell Death Dis
Chen J, Hu J, Guo X, Yang Y, Qin D, Tang X, Huang Z, Wang F, Hu D, Peng D, Yu B.   +10 more
europepmc   +1 more source

Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease [PDF]

, 2017
et al,, Hengstenberg, Christian, Stitziel, Nathan O   +2 more
core   +1 more source

Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment. [PDF]

Front Neurosci
Ashok K, Martinez T, Sesen J, Nasim S, Lang SS, Heuer G, Tucker A, Lopez-Ramirez MA, Smith ER, Ghalali A.   +9 more
europepmc   +1 more source

Ferritin-based disruptor nanoparticles: A novel strategy to enhance LDL cholesterol clearance via multivalent inhibition of PCSK9-LDL receptor interaction. [PDF]

Protein Sci
Incocciati A, Cappelletti C, Masciarelli S, Liccardo F, Piacentini R, Giorgi A, Bertuccini L, De Berardis B, Fazi F, Boffi A, Bonamore A, Macone A.   +11 more
europepmc   +1 more source